Pharmacy providers
Communications/Benefacts
Alberta Blue Cross® now offers online access to the most current up-to-date Pharmacy Benefacts and supplemental claiming information to assist with the submission of your direct bill drug claims.
-
July 2025 - Benefact number 1266
Fall 2025 immunizations
-
July 2025 - Benefact number 1265
Group and section number entry for direct-bill claims
-
July 2025 - Benefact number 1262
Alberta Vaccine Inventory (AVI) system update
-
June 2025 - Benefact number 1261
Tocilizumab added to the Alberta Biosimilar Initiative
-
June 2025 - Benefact number 1258
Infant formula and nutritional products prescribed by registered dietitians and nutritionists
-
June 2025 - Benefact number 1257
Tdap vaccine: Incorrect administration intervals
-
June 2025 - Benefact number 1256
Increased co-payment maximums for government-sponsored drug plans
-
June 2025 - Benefact number 1255
Declaration of a State of Local Emergency for Swan Hills, Alberta residents
-
May 2025 - Benefact number 1254
Alberta Blue Cross® promotes direct bill claims for Workers’ Compensation Board-Alberta
-
May 2025 - Benefact number 1252
Important information regarding potential disruption of postal services
-
May 2025 - Benefact number 1249
Enhancing the early refill authorization process
-
April 2025 - Benefact number 1248
Alberta Vaccine Booking System (AVBS) Vaccine Capacity Setting Reminder
-
March 2025 - Benefact number 1244
Influenza immunization season 2024-2025 – pharmacy end of season.
-
March 2025 - Benefact number 1243
Discontinuation of the Alberta Health Benefit for Ukrainian Evacuees program
-
March 2025 - Benefact number 1240
Important update regarding coverage of Inflectra
-
March 2025 - Benefact number 1239
Updates to approved prescriber for Nutritional Products
-
March 2025 - Benefact number 1238
Spring 2025 COVID-19 Immunization Program update
-
March 2025 - Benefact number 1237
Updating pharmacy direct deposit banking information (independent pharmacies only)
-
March 2025 - Benefact number 1236
Alberta Biosimilar Initiative Reminder for prescribers—Prolia switching deadline of May 1, 2025
-
March 2025 - Benefact number 1235
Administration of provincially funded vaccines in pharmacy and RSV vaccine update
-
January 2025 - Benefact number 1232
Alberta Blue Cross administering prescription drug benefits for Propak Systems Ltd.-group 84413, effective February 1, 2025
-
January 2025 - Benefact number 1231
Tips for successful online claim entry with Alberta Blue Cross
-
January 2025 - Benefact number 1230
Updating Alberta Blue Cross Pharmacy Inventory Map
-
January 2025 - Benefact number 1228
Diabetes Supply Limit Update for CGM Claimants
-
December 2024 - Benefact number 1226
Alberta Blue Cross® administering prescription drug benefits for Operating Engineers Local 955 Health & Wellness Trust (OE955)-group 23728, effective January 1, 2025.
-
December 2024 - Benefact number 1225
Addition of continuous glucose monitors for adults to Alberta government-sponsored plans
-
December 2024 - Benefact number 1223
The Government of Northwest Territories makes additions to the Biosimilars Initiative
-
December 2024 - Benefact number 1222
2024/2025 holiday hours schedule
-
November 2024 - Benefact number 1220
Assessment for Ensuring Continuity of Care in the event of emergency
-
November 2024 - Benefact number 1219
Pneumococcal vaccine: Incorrect administration intervals and eligibility reminder
-
November 2024 - Benefact number 1218
COVID-19 Rapid Antigen Test Kits Update
-
November 2024 - Benefact number 1217
Important information regarding potential disruption of postal services
-
November 2024 - Benefact number 1215
Denosumab added to the Alberta Biosimilar Initiative
-
October 2024 - Benefact number 1213
Pharmacy compensation update
-
September 2024 - Benefact number 1207
Respiratory Syncytial Virus (RSV) Vaccine
-
July 2025 - Benefact number 1267 - Drug Status
Importation of U.S.-labelled Disopyramide Phosphate Capsule due to the current shortage of Canadian-labelled (Rythmodan) disopyramide phosphate capsules
-
July 2025 - Benefact number 1263 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
-
June 2025 - Benefact number 1260 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
June 2025 - Benefact number 1259 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Removal of Temporary Benefit from Alberta Drug Benefit List (ADBL)
-
May 2025 - Benefact number 1253 – Drug Status
June 1, 2025 update to the ADBL
Resolved Product Shortage
Removal of a Temporary Benefit
-
April 2025 - Benefact number 1251 – Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
April 2025 - Benefact number 1247 – Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Product supply shortage addressed for ADBL
Removal of Temporary Benefits from ADBL
-
April 2025 - Benefact number 1245 – Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Removal of Temporary Benefits from ADBL
-
April 2025 - Benefact number 1242 – Drug Status
April 1, 2025 full updates for the Alberta Drug Benefit List (ADBL), Alberta Human Services Drug Benefit Supplement (HSDBS) and Palliative Coverage Drug Benefit Supplement (PCDBS)
-
March 2025 - Benefact number 1241 – Drug Status
Removal of temporary benefit from the Alberta Human Services Drug Benefit Supplement (HSDBS)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Product supply shortages addressed for ADBL
-
February 2025 - Benefact number 1234 – Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
-
January 2025 - Benefact number 1233 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Product supply shortages addressed for ADBL
-
January 2025 - Benefact number 1229 - Drug Status
Removal of temporary benefit from Alberta Drug Benefit List (ADBL)
-
December 2024 - Benefact number 1227 - Drug Status
Temporary Benefit added to the Alberta Human Services Drug Benefit Supplement (HSDBS)
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
December 2024 - Benefact number 1224 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
November 2024 - Benefact number 1221 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Removal of temporary benefit from the ADBL
Product supply shortages addressed for ADBL
-
November 2024 - Benefact number 1216 - Drug Status
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
Most commonly referenced
-
Increased co-payment maximums for government-sponsored drug plans
-
Enhancing the early refill authorization process
-
Temporary Change to Step Therapy for Deferasirox on Alberta Drug Benefit List (ADBL) effective March 7, 2024 for government-sponsored programs
-
Information regarding the Alberta Health Services AlbertaQuits program
-
Drug product shortage information
Assessing a drug shortage
Drug shortage resolutions
-
Update to website manual drug claim submissions
-
Palliative care support—updated claiming process for pre-filled syringes
-
Enhancing the coordination of benefits adjudication process
-
Alberta Blue Cross® group – Prescription Alternate-Funded Drugs
-
APHAP HIV Pre-Exposure Prophylaxis (PrEP) Program
-
Medical Assistance in Dying (MAID) drug program update
-
Drug Mifegymiso added to the Alberta Public Health Activities Program (APHAP) Women's Choice Program
-
Maintenance Medication Program (MMP) reminder
Limited restriction benefits
-
Average criteria for Champix revised for Alberta Government sponsored programs
-
Cyclobenzaprine 10 mg Tablets Restricted Benefit for Drug Programs Sponsored by Alberta Government
-
Pharmacy Compliance Verification Benefact Update Number 13
Claiming of Pediasure Oral Liquid
-
Pharmacy Compliance Verification Benefact Update Number 12
Claiming of additional dispensing fees
-
Pharmacy Compliance Verification Benefact Update Number 11
Frequent Dispensing Policy (FDP)
-
Pharmacy Compliance Verification Benefact Update Number 10
Claims submission for compound prescriptions
-
Pharmacy Compliance Verification Benefact Update Number 9
Claims submission for Assessments for a Trial Prescription
-
Pharmacy Compliance Verification Benefact Update Number 8
Timely reversal of claims not picked up by the patient
-
Pharmacy Compliance Verification Benefact Update Number 7
Prescription requirements for the Alberta Human Services Drug Benefit Supplement (HSDBS) coverage.
-
Pharmacy Compliance Verification Benefact Update Number 6
Claiming and dispensing Natural Health Products (NHP) and Over-the-counter (OTC) products
-
Pharmacy Compliance Verification Benefact Update Number 5
Pharmacy compliance verification review process during COVID-19 pandemic
Alberta Health temporarily suspends the requirement for “wet ink” signature for CACP/SMMA
-
Pharmacy Compliance Verification Benefact Update Number 4
Alberta Blue Cross® Pharmaceutical Services Provider Agreement
-
Pharmacy Compliance Verification Benefact Update Number 3
Alberta Blue Cross® Pharmaceutical Services Provider Agreement
-
Pharmacy Compliance Verification Benefact Update Number 2
Alberta Blue Cross® Pharmaceutical Services Provider Agreement
-
Pharmacy Compliance Verification Benefact number 1
Alberta Blue Cross® Pharmaceutical Services Provider Agreement
-
Pharmacy Compliance Verification Benefact number 1A
Alberta Blue Cross® Pharmaceutical Services Provider Agreement
Archive
-
October 2024 - Benefact number 1214 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Product supply shortages addressed for ADBL
-
October 2024 - Benefact number 1212 - Drug Status
Removal of Temporary Benefit from the Alberta Human Services Drug Benefit Supplement (HSDBS)
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
October 2024 - Benefact number 1208 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
September 2024 - Benefact number 1204 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
September 2024 - Benefact number 1203 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
August 2024 - Benefact number 1202 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Removal of temporary benefit from the ADBL
Product supply shortage addressed for ADBL
-
August 2024 - Benefact number 1200 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Removal of Temporary Benefit from the ADBL
-
July 2024 - Benefact number 1196 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Removal of Temporary Benefit from the ADBL
-
July 2024 - Benefact number 1194 - Drug Status
Importation of US-labelled Calcitriol 1 mcg/mL injection
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
July 2024 - Benefact number 1193 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Temporary benefit added to the ADBL
-
July 2024 - Benefact number 1192 - Drug Status
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
Temporary benefits added to the ADBL
Removal of temporary benefit from the ADBL
-
July 2024 - Benefact number 1191 - Drug Status
Importation of US-labelled Orencia SC 125 mg/ml Syringe Injection
Temporary Benefit added to the Alberta Drug Benefit List (ADBL)
-
June 2024 - Benefact number 1188 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Product supply shortages addressed for ADBL
-
June 2024 - Benefact number 1184 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
June 2024 - Benefact number 1183 - Drug Status
Importation of United States-authorized Carbamazepine extended-release tablet due to shortage of Canadian-authorized Carbamazepine extended-release tablet
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
June 2024 - Benefact number 1181 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the Alberta Human Services Drug Benefit Supplement (HSDBS)
Temporary benefit added to the Alberta HSDBS
-
October 2024 - Benefact number 1211
Alberta Blue Cross® reminds pharmacies of the ability to obtain real-time authorizations for over 100-day medication supply
-
October 2024 - Benefact number 1210
Alberta Outreach Immunization Program updates
-
October 2024 - Benefact number 1209
2024-2025 Fall Immunization Program Update – COVID-19 vaccine shipments
-
September 2024 - Benefact number 1206
Alberta fall immunization program 2024/2025
-
September 2024 - Benefact number 1205
Alberta Vaccine Booking System (AVBS) Pharmacy Communication
-
August 2024 - Benefact number 1201
Important Notice For NWT Pharmacy Providers
-
August 2024 - Benefact number 1199
Fall 2024/25 immunization program updates
August 31 is the last day for XBB administration
Tdap enabled in AVBS
-
August 2024 - Benefact number 1198
Alberta Outreach Immunization Program updates
-
August 2024 - Benefact number 1197
Suboxone Oral Film added to Opioid Agonist Therapy (OAT) Gap Coverage Program
-
July 2024 - Benefact number 1195
Evacuation order for the Municipality of Jasper, Alberta residents
-
June 2024 - Benefact number 1189
Alberta fall immunization program 2024/2025
-
June 2024 - Benefact number 1187
Tdap expansion - July 1, 2024
-
June 2024 - Benefact number 1186
Deletion of pneumococcal vaccine schedules
-
June 2024 - Benefact number 1185
Pneumococcal 20-valent Conjugate Vaccine (Pneu-C20):Prevnar 20TM in Pharmacy
-
June 2024< - Benefact number 1182
Product Identification Numbers (PINs) for Insulin Pump Therapy Program (IPTP)
-
June 2024 - Benefact number 1180
COVID-19 Oral Antiviral PaxlovidTM—REMINDER
-
May 2024 - Benefact number 1179 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Maximum Allowable Cost (MAC) pricing reminder for diclofenac under Alberta government sponsored drug programs
Removal of temporary benefits from the ADBL
-
May 2024 - Benefact number 1176 - Drug Status
Importation of United States-labelled Cholestyramine for Oral Suspension due to shortage
Reminder for imported temporary benefit (US) Colesevelam 625 mg Tablet
-
May 2024 - Benefact number 1175
Provider website reminders
-
May 2024 - Benefact number 1174
Provider website enhancements and reminders
-
May 2024 - Benefact number 1173 - Drug Status
Product supply shortages addressed for the Alberta Drug Benefit List (ADBL)
-
May 2024 - Benefact number 1172
Reminder: Paxlovid—no cost federal supply is still available to order until May 24, 2024
-
May 2024 - Benefact number 1171
Ustekinumab added to the Alberta Biosimilar Initiative
-
April 2024 - Benefact number 1170 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
-
April 2024 - Benefact number 1169 - Drug Status
Importation of United States-labelled colesevelam hydrochloride due to shortage of Canadian-labelled colesevelam hydrochloride
-
April 2024 - Benefact number 1168
COVID-19 immunization program update
-
April 2024 - Benefact number 1166 - Drug Status
April 1, 2024 Full Updates for the Alberta Drug Benefit List (ADBL), Alberta Human Services Drug Benefit Supplement (HSDBS) and Palliative Coverage Drug Benefit Supplement (PCDBS)
-
March 2024 - Benefact number 1165 - Drug Status
Reminder: adjustment to assessment for administration of COVID-19 vaccine and Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
March 2024 - Benefact number 1164
Alberta Vaccine Inventory (AVI) and provincially funded vaccine updates
-
March 2024 - Benefact number 1163
Influenza Immunication 2024 to 2024 – Pharmacy End of Season
-
March 2024 - Benefact number 1162
Important update: Paxlovid federal supply ending expiry dates, adjusting packs and commercial supply
-
March 2024 - Benefact number 1161 – Drug Status
Temporary Benefit added to the Alberta Drug Benefit List (ADBL)
Product supply shortages addressed for ADBL
-
February 2024 - Benefact number 1159 – Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Temporary benefit added to the ADBL
Removal of temporary benefits from the ADBL
Product supply shortages addressed for ADBL
-
February 2024 - Benefact number 1157
Ozempic (semaglutide) eligibility for Government of Northwest Territories (GNWT) health benefit programs
-
January 2024 - Benefact number 1155 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Removal of temporary benefit from the ADBL
Product supply shortages addressed for ADBL
-
January 2024 - Benefact number 1154 - Drug Status
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the ADBL
-
January 2024 - Benefact number 1153 - Drug Status
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
January 2024 - Benefact number 1152 - Drug Status
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
-
Benefact number 1116 - Alberta Influenza Immunization Program 2023/2024
-
Benefact number 1013 - Addition of Continuous Glucose Monitors to Alberta government-sponsored plans
Submission of glucose monitoring systems for Alberta Blue Cross® employer-sponsored group and individual health plans
-
December 2023 - Alberta Blue Cross® and Workers’ Compensation Board –Alberta (WCB-Alberta) continue to expand access to direct billing of prescription drugs for worker claims
-
December 2023 - Narcotic Transition Services (NTS)
-
December 2023 - Benefact number 1148 - Drug Status
Importation of United Kingdom-labelled Glyceryl Trinitrate Nitroglycerin) 0.4 mg/dose Sublingual Metered Dose Spray due to shortage of Canadian-authorized nitroglycerin sublingual sprays
Temporary benefit added to the Alberta Drug Benefit List(ADBL)
-
November 2023 - Benefact number 1145 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
-
November 2023 - Eligible Insulin Pumps and Pump Supplies are available as limited-use benefits for Government of Northwest Territories (GNWT) health benefit programs
-
October 2023 - Assessment for Ensuring Continuity of Care in the Event of a Declaration of a State of Emergency or Declaration of a State of Local Emergency
-
October 2023 - Benefact number 1139 - Drug Status
Importation of United States-labelled Vigabatrin 500 mg Oral Powder Packet due to shortage of vigabatrin
-
October 2023 - Benefact number 1138 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Temporary benefits added to the ADBL
Removal of temporary benefit from the ADBL
Product supply shortages addressed for ADBL
-
October 2023 - Alberta Health Influenza Antiviral Drug Policy as applied to vulnerable populations living in congregate living settings
-
October 2023 - Benefact number 1136 - Drug Status
Importation of United States-labelled Prazosin Hydrochloride Capsules due to shortage of Prazosin Hydrochloride Tablets
-
September 2023 - Benefact number 1129 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)
Product supply shortages addressed for ADBL
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
September 2023 - Benefact number 1128 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
July 2023 - Northwest Territories Wildfire Emergency
-
July 2023 - Benefact number 1122 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online Temporary benefits added to the ADBL
Removal of temporary benefit from the ADBL
Product supply shortage addressed for ADBL
-
July 2023 - Benefact number 1120 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Removal of temporary benefits from the Alberta Human Services Drug Benefit Supplement (HSDBS)
-
July 2023 - Enhanced website functionality accommodates product status and pricing inquiries
-
June 2023 - Benefact number 1117 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
June 2023 - Benefact number 1115 - Drug Status
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Removal of Temporary Benefits from the ADBL
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
June 2023 - Enhancements to Medical Supplies and Equipment claiming for the Government of Northwest Territories (GNWT) Extended Health Benefit programs
-
June 2023 - Alberta Blue Cross® and Workers’ Compensation Board – Alberta (WCB-Alberta) continue to expand access to direct billing of prescription drugs for worker claims
-
June 2023 - Updates to eligibility for flash and continuous glucose monitor (CGM) systems effective June 9, 2023, for Government of the Northwest Territories (GNWT) Seniors (Group 60), Specified Disease Conditions (Group 21992) and Métis Health Benefit (Group 19866) programs
-
June 2023 - Benefact number 1110 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Temporary Benefit added to the ADBL
-
May 2023 - Benefact number 1109 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
May 2023 - Submitting claims for prescriptions from Physicians Assistants
-
May 2023 - Alberta Wildfire Emergency
-
May 2023 - Benefact number 1106 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Removal of Temporary Benefits from the Alberta Drug Benefit List (ADBL)
Temporary Benefits added to the Alberta Drug Benefit List (ADBL)
-
May 2023 - Declaration of a State of Local Emergency for Parkland and Yellowhead Counties, Alberta residents
-
April 2023 - Benefact number 1103 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Temporary Benefits added to the Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the Alberta Drug Benef it List (ADBL)
-
April 2023 - Update to Pharmacy Teams on Importation Liquid Pediatric Ibuprofen with Child-Resistant Packaging
-
April 2023 - Benefact number 1101 - Drug Status
Temporary Benefits added to the Alberta Drug Benefit List (ADBL)
Removal of Temporary Benefit from the Alberta Drug Benefit List (ADBL)
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
April 2023 - Influenza immunization 2022 to 2023—pharmacy end of season
-
March 2023 - Benefact number 1099 - Drug Status
April 1, 2023, Full Updates for the Alberta Drug Benefit List (ADBL), Alberta
Human Services Drug Benefit Supplement (HSDBS) and Palliative Coverage Drug
Benefit Supplement (PCDBS)
-
March 2023 - Benefact number 1097 - Drug Status
Reminder: ONLY SELECT Workers’ Compensation Board – Alberta (Group 23737, Section A) worker claims are eligible for direct bill through Alberta Blue Cross®
Updates to the Alberta Blue Cross® Critical Supply List
Temporary Benefit added to the Alberta Drug Benefit List (ADBL)
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
March 2023 - Update to Pharmacy Teams on Importation Liquid Pediatric Acetaminophen with Child- Resistant Packaging
-
March 2023 - Benefact number 1093 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)
-
February 2023 - Benefact number 1092 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
February 2023 - Enhancing the pharmacy provider website provides oral compound authorizations in real-time to better meet your needs
-
February 2023 - Benefact number 1090 - Drug Status
Drug product shortage information
Assessing a drug shortage
Drug shortage resolutions
-
February 2023 - Updates to the Insulin Pump Therapy Program (IPTP) coverage for insulin pumps and supplies
-
February 2023 - Enhancement to the claiming process for eligible flash and continuous glucose monitoring systems for Government of Northwest Territories (GNWT) health benefit programs
-
February 2023 - Benefact number 1084 - Drug Status
Quarterly update regarding the Authorized Adjustment
Temporary Benefit added to the Alberta Drug Benefit List (ADBL)
Removal of Temporary Benefits from the ADBL
Product supply shortage addressed for the ADBL
-
January 2023 - Workplace naloxone: information for pharmacy teams
-
January 2023 - Benefact number 1082 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Removal of Temporary Benefit from the Alberta Drug Benefit List (ADBL)
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
-
January 2023 - Benefact number 1081 - Drug Status
Importation of Cyprus-labelled Moxilen (Amoxicillin) 250 mg/5mL suspension due to shortage of antibiotic oral suspensions in Canada
-
January 2023 - Benefact number 1080 - Drug Status
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
-
December 2022 - Additional insulin pumps and associated supplies added to the Insulin Pump Therapy Program (IPTP).
-
December 2022 - Benefact number 1078 - Drug Status
Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
-
December 2022 - Benefact number 1076 - Drug Status
Importation of USA – Children’s TYLENOL Oral Suspension due to shortage of pediatric analgesics
Additional temporary benefit added to the Alberta Drug Benefit List (ADBL) due to amoxicillin oral suspension shortage
Temporary benefit added to the ADBL
-
November 2022 - Changes to ASEBP drug management programs
-
November 2022 - Benefact number 1074 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
-
November 2022 - Benefact number 1073 - Drug Status
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
-
November 2022 - Benefact number 1072 - Drug Status
Coverage of Pediatric Acetaminophen and Ibuprofen and Temporary Benefits
-
November 2022 - Benefact number 1070 - Drug Status
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
Quarterly update regarding the Authorized Adjustment
-
October 2022 - Benefact number 1069 - Drug Status
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the ADBL
Product supply shortage addressed for ADBL
-
October 2022 - Benefact number 1068 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
-
October 2022 - Benefact number 1066 - Drug Status
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
-
October 2022 - Lowest cost equivalent drug adjudication
-
October 2022 - Alberta Influenza Immunization Program 2022/2023 – updating inventory on the pharmacy provider website
-
October 2022 - Changes to the claiming process for our national members
-
October 2022 - Alberta Blue Cross® reminds pharmacies of the ability to obtain real-time authorizations for more than 100-day medication supplies
-
September 2022 - Alberta Health Services introduces the Alberta Lung Cancer Screening Pilot as part of AlbertaQuits (Group number 23699, Section D)
-
September 2022 - Benefact number 1061 - Drug Status
National Day for Truth and Reconciliation—September 30, 2022
Alberta Drug Benefit List (ADBL) interim update now available online
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
-
September 2022 - Alberta Health Influenza Antiviral Drug Policy as applied to vulnerable populations living in congregate living settings
-
September 2022 - Benefact number 1059 - Drug Status
Temporary benefit added to the Palliative Coverage Drug Benefit Supplement (PCDBS)
Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)
-
September 2022 - Benefact number 1057 - Drug Status
Product supply shortage addressed for the Alberta Drug Benefit List (ADBL)
-
September 2022 - Alberta Public Health Activities Program (APHAP) Alberta Influenza Immunization Program 2022/2023
Key updates for this year—COVID-19 vaccine considerations, Alberta Vaccine Inventory Reporting Process, Alberta Vaccine Booking System
-
August 2022 - Benefact number 1053 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Product supply shortage addressed for the Alberta Drug Benefit List (ADBL)
-
August 2022 - Benefact number 1052 - Drug Status
Reminder of Maximum Allowable Cost (MAC) pricing reinstatement to combination Angiotension-Converting Enzyme (ACE) inhibitor groupings
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
August 2022 - Benefact number 1051 - Drug Status
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Temporary Benefit added to the Alberta Human Services Drug Benefit Supplement (HSDBS)
-
August 2022 - Update to website manual drug claim submissions
-
August 2022 - Benefact number 1047 - Drug Status
Product supply shortage addressed for the Alberta Drug Benefit List (ADBL)
-
August 2022 - Claim submission tips for 1976 drug authorization claims
-
August 2022 - Benefact number 1044 - Drug Status
Importation of UK-labelled Alfamino Infant Formula Powder and US-labelled Gerber Good Start Extensive HA Infant Formula Powder due to shortages of specialized infant formula
-
July 2022 - Benefact number 1043 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the Alberta Human Services Drug Benefit Supplement (HSDBS)
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
-
July 2022 - Benefact number 1042 - Drug Status
Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
July 2022 - Enhanced website functionality accommodates manual drug claim submissions
-
July 2022 - Benefact number 1040 - Drug Status
Importation of USA - Cortef 10 mg Tablet due to shortage
-
June 2022 - Benefact number 1038 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Insulin Pump Therapy Program termination on hold
Product supply shortages addressed for the Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Human Services Drug Benefit Supplement (HSDBS)
Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)
-
June 2022 - Benefact number 1037 - Drug Status
Update on shortage of specialized infant formula Importation of United States-labelled Nutramigen A+ Concentrate Infant Formula due to shortage of specialized infant formula
-
June 2022 - Declaration of a state of local emergency for Calgary and Municipal District of Bighorn, Alberta residents
-
June 2022 - Benefact number 1035 - Drug Status
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Removal of a temporary benefit from the Alberta Drug Benefit List (ADBL)
-
June 2022 - Benefact number 1034 - Drug Status
Importation of United States-labelled Nutramigen A+ Concentrate Infant Formula due to shortage of specialized infant formula
-
May 2022 - Benefact number 1033 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
-
May 2022 - Enhancements to insulin pump supply claiming process for Government of Northwest Territories (GNWT) health benefit programs
-
Nay 2022 - Benefact number 1031 - Drug Status
Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Human Services Drug Benefit Supplement (HSDBS)
-
May 2022 - Ukrainian Evacuee Temporary Health Benefits Program
-
May 2022 - Benefact number 1029 - Drug Status
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
-
May 2022 - Insulin Pump Therapy Program changes
-
April 2022 - Benefact number 1026 - Drug Status
Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
April 2022 - Benefact number 1024 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Pan-Canadian Select Molecule Price Initiative for generic drugs
-
April 2022 - Opioid Agonist Therapy (OAT) Gap Coverage Program
Reminder: Humira delisted on government-sponsored drug plans
-
April 2022 - Tramadol compound PIN update
Paxlovid™ dispensing update
-
March 2021 - Benefact number 1021 - Drug Status
April 1, 2022 Full Updates for the Alberta Drug Benefit List (ADBL), Alberta Human Services Drug Benefit Supplement (HSDBS) and Palliative Coverage Drug Benefit Supplement (PCDBS)
-
March 2022 - Ukrainian Evacuee Temporary Health Benefits Program
-
March 2022 - Alberta Public Health Activities Program (APHAP) influenza immunization end of 2021 to 2022 season
-
March 2022 - Alberta Blue Cross® individual and employer-sponsored group plans—step therapy dosing controls
-
February 2022 - Benefact number 1016 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
pan-Canadian Select Molecule Price Initiative for Generic Drugs
Product supply shortage addressed for the Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
February 2022 - Addition of Continuous Glucose Monitors to Alberta government-sponsored plans
Submission of glucose monitoring systems for Alberta Blue Cross® employer-sponsored group and individual health plans
-
February 2022 - Palliative care support—updated claiming process for pre-filled syringes
-
January 2022 - BIOSIMILARS INITIATIVE UPDATE – Delisting of Humalog, reminders of NovoRapid and Humira
Alberta Drug Benefit List (ADBL) interim update now available online
Temporary benefit added to the ADBL
-
December 2021 - Benefact number 1004 - Drug Status
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
-
December 2021 - The Government of the Northwest Territories announces Biosimilars Initiative
-
December 2021 - Alberta Blue Cross® group plans–enhanced step therapy management to apply dosing controls
-
December 2021 - Benefact number 999 - Drug Status
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the Palliative Coverage Drug Benefit Supplement (PCDBS)
-
December 2021 - Blood glucose test strip claims for Alberta Blue Cross® employer-sponsored group and personal health plans and Alberta government-sponsored programs
-
December 2021 - Update – PINs for blood glucose test strip claims for Alberta Blue Cross® employer-sponsored group and personal health plans
-
November 2021 - Benefact number 995 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)
-
November 2021 - Verify you are using a valid Alberta prescriber identification number and reference code at time of claim
-
November 2021 - Sublocade added to Opioid Agonist Therapy (OAT) Gap Coverage Program
-
November 2021 - Benefact number 991 - Drug Status
Product Supply Shortages Addressed for Alberta Drug Benefit List (ADBL)
-
October 2021 - Benefact number 990 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
-
October 2021 - Extension of special authorizations for government-sponsored plans
-
October 2021 - Influenza immunization program updates for pharmacy
-
October 2021 - Alberta Health Influenza Antiviral Drug Policy as applied to Vulnerable Populations Living in Congregate Living Settings
-
October 2021 - Benefact number 986 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
October 2021 - Alberta vaccine records
Vaccine administration claims
Unique Lifetime Identifier (ULI) versus PHN
-
September 2021 - Benefact number 983 - Drug Status
Trurapi added to the Alberta Biosimilar Initiative
-
September 2021 - A Reference guide for administering and claiming influenza vaccines
-
September 2021 - Benefact number 982 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update for October 1, 2021
Product added to Opioid Agonist Therapy (OAT) Gap Coverage Program
-
September 2021 - Benefact number 981 - Drug Status
Product added to Opioid Agonist Therapy (OAT) Gap Coverage Program
Product supply shortages addressed for ADBL
-
September 2021 - Alberta Influenza Immunization Program 2021-22
-
September 2021 - Alberta Health Insulin Pump Therapy Program— claiming for blood glucose test strips
-
August 2021 - Benefact number 975 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available
-
August 2021 - Changes to coverage for diabetes supplies for Alberta Government-sponsored programs
-
August 2021 - Benefact number 972 - Drug Status
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Importation of USA-Depo-Provera 150 mg/ml Injection due to Shortage
-
July 2021 - Admelog added to the Alberta Biosimilar Initiative
-
July 2021 - Changes to coverage for diabetes supplies for Alberta Government-sponsored programs
-
July 2021 - Benefact number 969 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Product supply shortages addressed for ADBL
Removal of temporary benefits from the ADBL
-
July 2021 - Additional information regarding enhancements to Specified
Disease Conditions, Seniors and Métis Health Benefits Programs
-
June 2021 - Enoxaparin added to the Alberta Biosimilar Initiative
Pneumovax-23 change from vials to pre-filled syringes
-
June 2021 - Benefact number 965 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
Product supply shortages addressed for ADBL
Removal of temporary benefits from the ADBL
-
June 2021 - Enhancements to Specified Disease Conditions, Seniors and Metis Health Benefits Programs
-
June 2021 - Benefact number 963 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
May 2021 - Palliative care support expanded—pre-filled syringes
Quarterly update regarding the Authorized Adjustment
-
May 2021 - Benefact number 961 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Product supply shortages addressed for ADBL
Removal of imported temporary benefits from ADBL
-
May 2021 - Benefact number 959 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the ADBL
Temporary benefit added to the ADBL
-
May 2021 - Opioid Agonist Therapy (OAT) Gap Coverage Program and Extension
-
April 2021 - Benefact number 956 - Drug Status
Adalimumab added to the Alberta Biosimilar Initiative
Product added to Opioid Agonist Therapy (OAT) Gap
-
April 2021 - Benefact number 955 - Drug Status
Alberta Drug Benefit List (ADBL) interim update now available online
Temporary benefit added to the ADBL
Product supply shortages addressed for ADBL
-
April 2021 - Benefact number 952 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Temporary benefit added to the ADBL
Temporary benefit added to the Alberta Human Services Drug Benefit Supplement (HSBDS)
-
March 2021 - Benefact number 950 - Drug Status
April 1, 2021 Full Updates for the Alberta Drug Benefit List (ADBL),Alberta Human Services Drug Benefit Supplement (HSDBS) and Palliative Coverage Drug Benefit Supplement (PCDBS)
-
March 2021 - End date for 2020/2021 Alberta Public Health Activities Program (APHAP) Influenza Immunization Season
-
March 2021 - Benefact number 944 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the Alberta Drug Benefit List (ADBL)
-
February 2021 - Reminder: ONLY Alberta Retired Teachers’ Association (ARTA) “A” and “Q” sections from group 19930 move to Green Shield Canada
Additional products added to the Alberta Public Health Activities Program (APHAP)
-
February 2021 - Benefact number 935 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
-
February 2021 - Manual Drug Claim Form Enhancements
-
February 2021 - Reminder: Lantus delisted on government-sponsored drug plans
Quarterly update regarding the Authorized Adjustment
-
February 2021 - Benefact number 931 - Drug Status
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Drug BenefitList (ADBL)
-
January 2021 - Enhanced validation of valid prescriber identification numbers for claims adjudication
-
January 2021 - Benefact number 929 - Drug Status
Alberta Drug Benefit List (ADBL) Interim Update now available online
-
January 2021 - Benefact number 928 - Drug Status
Alberta Drug Benefit List (ADBL) update now available online
Temporary change to Step Therapy for Direct-Acting Oral Anticoagulants (DOACs)
-
January 2021 - Alberta Biosimilars Initiative update
-
Janurary 2021 - Benefact number 926 - Drug Status
Alberta Retired Teachers’ Association (ARTA), Group 19930 “A” Sections Only
Removal of Temporary Benefit from the Alberta Drug Benefit List (ADBL)
Product supply shortages addressed for Alberta Drug Benefit List (ADBL)
-
December 2020 - Introduction of Nutritional Product, Package Size, and UPC Listing now available under the Pharmacy Providers Resources page.
-
December 2020 - Step therapy for select narcotic drug products effective January 1, 2021, for Alberta Blue Cross® individual and employer-sponsored group plans.
-
December 2020 - Retroactive claims adjustments for Assessment for the Administration of a Publicly Funded Vaccine Fee.
-
December 2020 - Protection of Students with Life-threatening Allergies Act (PSLTA)—epinephrine auto-injector device supply for 2021.
-
October 2020 - Alberta’s Biosimilars Initiative update
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
-
October 2020 - Métis Nation of Alberta nicotine replacement therapy program (group number 23713 section A)
-
October 2020 - Increase to Assessment for the Administration of a Publicly Funded Vaccine fee
Retroactive claims adjustment
-
October 2020 - Quantity authorizations for Alberta Health programs reinstated
-
September 2020 - Enhanced website provides topical compound authorizations in real time
-
September 2020 - Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2020/2021
-
July 2020 - Changes to the calculation of the co-payment for government-sponsored plans
(Group 1 and 66) for products on the Critical Supply Product List
-
July 2020 - Extension of special authorizations for government-sponsored plans
Temporary Benefit added to the Alberta Drug Benefit List (ADBL)
-
June 2020 - Influenza planning for the 2020/2021 season
-
June 2020 - Alberta Biosimilars Initiative Update
Year-end update on the Holdback Policy
Removal of temporary benefit from Alberta Human Services Drug Benefit
Supplement (HSDBS)
-
June 2020 - Alberta Biosimilars Initiative Updates
-
June 2020 - Update on measures to prevent drug product shortages
Information about products in a critical supply situation
Quantity authorization
-
June 2020 - Alberta Biosimilars Initiative Updates
-
May 2020 - Importation of UK-Labelled Teva-Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to Shortage
Temporary change to Step Therapy for Direct-Acting Oral Anticoagulants (DOACs) on the Alberta Drug Benefit List (ADBL) effective May 15, 2020 for government-sponsored programs
-
April 2020 - Government coverage options for those impacted by COVID-19
-
April 2020 - Alberta Biosimilar Initiative – update to switching timelines in response to COVID-19
Temporary access to Humira for Crohn’s Disease due to COVID-19
-
April 2020 -Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Temporary changes to coverage for Nicotine Products under the Alberta Human Services Drug Benefit Supplement
Changes to the Government of Alberta’s Palliative Coverage Program
-
April 2020 - Enhanced access to Opioid Agonist Therapy (OAT)
-
April 2020 - Manual Drug Claim forms—enhancement of submission process
-
March 2020 - Alberta Public Health Activities Program (APHAP) Influenza Immunization end of 2019/2020 season
-
March 2020 - Updates regarding COVID-19 Pandemic
-
March 2020 - Updated Ministerial Order now available & Third quarter update on the Holdback policy
-
February 2020 - Alberta Health’s Coverage for Seniors program—income-based deductibles to be introduced in 2020
-
February 2020 - Reminder #2—Eligibility changes take effect March 1, 2020 to Alberta Health’s Coverage for Seniors Program.
-
February 2020 - Payment date change for AISH and Income Support
-
February 2020 - Reminder Eligibility changes to Coverage for Seniors Program
-
January 2020 - Alberta Biosimilar Initiative—patient support letter and resources
-
January 2020 - Alberta Health’s Coverage for Seniors Program—eligibility changes effective March 1, 2020
-
December 2019 - Calgary Catholic School District Group 14200-Drug Benefit Plan enhancements effective January 1, 2020
-
December 2019 - Have you received and returned your First Amending Agreement?
-
December 2019 - Pharmacies supporting local schools for the Protection of Students with Life-threatening Allergies Act
-
December 2019 - Alberta Health announces an important change to coverage for biologic products under Alberta government sponsored programs
-
December 2019 - Important reminder: Alberta Health’s change to coverage for select angiotensin-converting enzyme inhibitors (ACEIs), HMG-COA reductase inhibitors (statins) and calcium-channel blocking agents (CCBs) under Alberta government sponsored programs
-
December 2019 - Coverage criteria updates for select benefits of Government of Northwest Territories (GNWT) health benefit programs
-
December 2019 - Important reminder: Alberta Health’s change to coverage for select angiotensin-converting enzyme inhibitors (ACEIs), HMG-COA reductase inhibitors (statins) and calcium-channel blocking agents (CCBs) under Alberta government sponsored programs
-
November 2019 - Alberta Health announces an important change to coverage for select angiotensin-converting enzyme inhibitors (ACEIs), HMG-COA reductase inhibitors (statins) and calcium-channel blocking agents (CCBs) under Alberta government sponsored programs
-
October 2019 - Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2019/2020
-
July 2019 - First quarter update on the Holdback Policy
-
July 2019 - Nazia Pharmacy termination notice
-
May 2019 - Ensuring Continuity of Care for Residents displaced by the Northwest Alberta wildfire
-
March 2019 - OHIP+Program Changes
-
March 2019 - Changes to the payment summary reconciliation reports
-
March 2019 - Pharmacy funding Framework
-
February 2019 - Coverage criteria updates for select benefits of Government of Northwest Territories (GNWT) health benefit programs
-
January 2019 - Update to the Insulin Pump Therapy (IPT) Program
-
December 2018 - Alberta Blue Cross® Pharmaceutical Services Provider Agreement Compliance Verification Review process
-
November 2018 - Pneumococcal Polysaccharide 23-Valent Vaccine (Pneumo-P 23) added to the list of provincially funded vaccines for pharmacists
-
November 2018 - Diphtheria-Tetanus-Acellular Pertussis Combined Vaccine (dTap) added to the list of provincially-funded vaccines for pharmacists
-
October 2018 - Influenza Antiviral Drug Policy - Alberta Public Health Activities Program (APHAP)
-
September 2018 - Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2018/2019
-
August 2018 - Blood Glucose Test Strip Limit for employer sponsored coverage
-
July 2018 - Update to greater than 100 days’ medication supply for the clients of the Government of Northwest Territories (GNWT)
-
May 2018 - Direct bill batch claim processing: software updates for Frequent Dispensing Policy Special Services Codes
-
May 2018 - Alberta Blue Cross® Pharmaceutical Services Provider Agreement update #4
-
May 2018 - Alberta Blue Cross® Pharmaceutical Services Provider Agreement update #3
-
April 2018 - Take Home Naloxone (THN) Program Update
-
April 2018 - Alberta Blue Cross® Pharmaceutical Services Provider Agreement update #2
-
April 2018 - Alberta Blue Cross® Pharmaceutical Services Provider Agreement update #1
-
February 2018 - Pan-Canadian Competitive Value Price Initiative for Generic Drugs
-
February 2018 - Special Announcement: Pharmaceutical Services Provider Agreement
-
February 2018 - Pan-Canadian Pharmaceutical Alliance